Zomedica Corp.
ZOM was delisted on the 4th of March, 2025.
25 hedge funds and large institutions have $4.8M invested in Zomedica Corp. in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 10 reducing their positions, and 8 closing their positions.
47% more capital invested
Capital invested by funds: $3.26M → $4.8M (+$1.54M)
11% less funds holding
Funds holding: 28 → 25 (-3)
38% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 8
70% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IP
Isthmus Partners
Madison,
Wisconsin
|
+$13K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$12.1K |
| 3 |
Renaissance Technologies
New York
|
+$11.2K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$6.38K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
+$3.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$116K |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$75K |
| 3 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$55.4K |
| 4 |
Goldman Sachs
New York
|
-$47K |
| 5 |
Morgan Stanley
New York
|
-$34.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Bank of America
Charlotte,
North Carolina
| – | -$14K | -63,915 | Closed |
|
|
VF
27
Virtu Financial
New York
| – | -$5K | -21,718 | Closed |
|
|
TRCT
28
Tower Research Capital (TRC)
New York
| – | -$5K | -19,635 | Closed |
|
29
Legal & General Group
London,
United Kingdom
| – | -$1K | -5,852 | Closed |
|
30
Barclays
London,
United Kingdom
| – | -$1K | -3,064 | Closed |
|
31
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | -$52 | -167 | -40% |
|
ZOM Hedge Fund Activity: Q3 2019 in Review
25 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q3 2019, worth a combined $4.8M — up 47% from $3.26M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of ZOM and 5 opened new positions — a net loss of 3 holders — while 10 trimmed existing stakes and 3 added.
The largest buyer was Isthmus Partners, opening a new position worth an estimated $13K. The largest seller was Millennium Management, cutting an estimated $116K.
- 25 institutional investors held Zomedica Corp. (ZOM) as of Q3 2019, down from 28 in Q2 2019.
- Funds reported $4.8M of Zomedica Corp. stock for Q3 2019, up 47% quarter-over-quarter.
- 5 funds opened new Zomedica Corp. positions in Q3 2019 and 8 closed out, a net change of -3 holders.
- The largest Zomedica Corp. buyer in Q3 2019 was Isthmus Partners, an estimated $13K added.
- The largest Zomedica Corp. seller in Q3 2019 was Millennium Management, an estimated $116K sold.
Based on aggregated 13F filings for Q3 2019.